AI ICSR queue (demo)

AI mode:AssistFull auto available on Professional

1
AI: valid ICSR

1
AI: not an ICSR

1
Needs human

4
Screened total

Likely ICSRpendingPubMed + Europe PMC[Sample drug A] · ID 00000001 (sample)

Acute pancreatitis after initiation of [Sample drug A]: a case report

Identifiable patient · suspect drug · adverse event · case report

AIValid ICSRconfidence 0.93

✓ Identifiable patient a 58-year-old woman
✓ Identifiable reporter We report
✓ Suspect product four weeks after starting [Sample drug A]
✓ Adverse event developed acute pancreatitis

Single named case with age and sex, authors as reporters, the product as suspect and a clear adverse event.

Age: 58 years · Sex: female · Events: acute pancreatitis · Seriousness: hospitalisation · Outcome: recovered after discontinuation · Suspect drug: [Sample drug A] · Dose: 0.5 mg weekly · Country: India

Sample AI output for the demo.

Buttons disabled in the demo

PossiblependingEurope PMC (preprint)[Sample drug A] · ID 00000002 (sample)

Hepatic enzyme elevations in a cohort treated with [Sample drug A]

Suspect drug · adverse event · no individual patient

AINot an ICSRconfidence 0.81

✗ Identifiable patient 312 patients were included
✓ Identifiable reporter Authors listed
✓ Suspect product treated with [Sample drug A]
✓ Adverse event ALT elevations

Aggregate cohort data only; no individual identifiable patient. Below the 0.85 auto threshold, so it goes to a human.

Events: ALT increased · Suspect drug: [Sample drug A]

Sample AI output for the demo.

Buttons disabled in the demo

PossiblependingCrossref[Sample drug A] · ID 00000003 (sample)

Severe hypoglycaemia in an elderly patient on [Sample drug A] and a sulfonylurea

Adverse event · patient mention

AINeeds human reviewconfidence 0.62

✓ Identifiable patient an 81-year-old man
✓ Identifiable reporter We describe
? Suspect product on [Sample drug A] and glimepiride
✓ Adverse event severe hypoglycaemia

Valid case elements, but the abstract attributes the event mainly to the co-medication; suspect role of the product is unclear.

Age: 81 years · Sex: male · Events: hypoglycaemia · Seriousness: hospitalisation · Outcome: recovered · Suspect drug: [Sample drug A], glimepiride · Country: not stated

Sample AI output for the demo.

Buttons disabled in the demo

Not relevantpendingOpenAlex[Sample drug A] · ID 00000004 (sample)

Cost-effectiveness of [Sample drug A] in type 2 diabetes

No adverse event terms matched

Buttons disabled in the demo

Sample weekly report

ID	Source	Title	Triage	AI decision	Confidence	Decision
00000001	PubMed + Europe PMC	Acute pancreatitis after initiation of [Sample drug A]: a case report	Likely ICSR	Valid ICSR	0.93	pending
00000002	Europe PMC (preprint)	Hepatic enzyme elevations in a cohort treated with [Sample drug A]	Possible	Not an ICSR	0.81	pending
00000003	Crossref	Severe hypoglycaemia in an elderly patient on [Sample drug A] and a sulfonylurea	Possible	Needs human review	0.62	pending
00000004	OpenAlex	Cost-effectiveness of [Sample drug A] in type 2 diabetes	Not relevant	–		pending

AI assessments come from a general-purpose open model and can be wrong. Every AI output and who or what made the final decision are logged. Your company remains responsible for case validity and reporting.